Skip to content

Lucid Diagnostics LUCD Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Guardant Health logo
Guardant HealthGH
$100.63M
Quest Diagnostics logo
Quest DiagnosticsDGX
$0-100%
Danaher logo
DanaherDHR
$0-100%
Opko Health logo
Opko HealthOPK
$8.49M+51.3%

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$204.13M+58.5%
Enterprise value$177.85M+78.0%
P/S39.8×+10.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
Net margin-876.7%-254pp
FCF margin-1,099.6%

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromConvertibleDebt.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Diagnostics's debt issuance proceeds?
Lucid Diagnostics (LUCD) reported debt issuance proceeds of $0 in Q1 2026.
How has Lucid Diagnostics's debt issuance proceeds changed year-over-year?
Lucid Diagnostics's debt issuance proceeds decreased by 100.0% year-over-year, from $360K to $0.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.